You finally have investor interest. A couple of angels like the idea, one says “We usually do SAFEs,” another asks if you’re open to a convertible note, and suddenly you’re deep in legal blog posts at ...

Convertible notes are agreements where investors lend money to a company, with the expectation that the loan will convert into equity at a later date, usually during the next significant financing ...

Calgary, Alberta / October 15, 2025 –TheNewswire -Credissential Inc. (“Credissential” or the “Company”) (CSE: WHIP), a vertically integrated AI software development companyis pleased to announce a non ...

Bitdeer Technologies’ shares slid sharply today after announcing plans to raise $300 million through a private sale of convertible senior notes. Bitdeer Technologies’ shares slid sharply today after ...

You’re a few months into building. You have early users, a half-working product, and one investor asking for your “valuation expectations.” You have no idea what to say. A friend tells you to “just ...

SEATTLE--(BUSINESS WIRE)-- Impinj, Inc. (PI), today announced that it entered into separate, privately negotiated repurchase agreements with certain holders of its 1.125% Convertible Notes due 2027 ...

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (“Mirion”) (NYSE: MIR), today announced its intent to offer $250.0 million aggregate principal amount of Convertible Senior Notes due 2031 (the ...

AST SpaceMobile Announces Proposed Repurchases of up to $300.0 Million Convertible Senior Notes to be Funded By Concurrent Registered Direct Offerings of Class A Common Stock AST SpaceMobile, Inc.

Bit Digital (BTBT) shares slid 8% at the U.S. market open, dropping to $2.92 after the company announced an upsized $135 million convertible note offering. Bit Digital increased the size of the 4.00% ...

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of ...